Monday, November 3, 2014

Blood Cancer Journal - Table of Contents alert Volume 4 October 2014

If you are unable to see the message below, click here to view.
Blood Cancer Journal

TABLE OF CONTENTS

Volume 4, October 2014

In this issue
Original Articles
Letters to the Editor
Corrigendum
Sign up for e-alerts Sign up for e-alerts
Web feed
Advertisement

Blood Cancer Journal: submit your next manuscript

Blood Cancer Journal is an open access journal, publishing research and review articles of the highest quality on hematologic malignancies and related disorders, and recently received a first Impact Factor of 2.884*.

Discover the benefits of publishing with Blood Cancer Journal.

*2013 Journal Citation Reports? Science Edition (Thomson Reuters, 2014)
 

Original Articles

Top

Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma

S E Assouline, J Chang, B D Cheson, R Rifkin, S Hamburg, R Reyes, A-M Hui, J Yu, N Gupta, A Di Bacco, Y Shou and P Martin

Blood Cancer J 2014 4: e251; 10.1038/bcj.2014.71

Abstract | Full Text

Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma

A Barreca, C Martinengo, L Annaratone, L Righi, A Chiappella, M Ladetto, A Demurtas, L Chiusa, A Stacchini, N Crosetto, A van Oudenaarden and R Chiarle

Blood Cancer J 2014 4: e249; 10.1038/bcj.2014.67

Abstract | Full Text

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients

R E Clark, J Bell, J O Clark, B Braithwaite, U Vithanarachchi, N McGinnity, T Callaghan, S Francis and R Salim

Blood Cancer J 2014 4: e255; 10.1038/bcj.2014.79

Abstract | Full Text

Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group

F Hayakawa, T Sakura, T Yujiri, E Kondo, K Fujimaki, O Sasaki, J Miyatake, H Handa, Y Ueda, Y Aoyama, S Takada, Y Tanaka, N Usui, S Miyawaki, S Suenobu, K Horibe, H Kiyoi, K Ohnishi, Y Miyazaki, S Ohtake, Y Kobayashi, K Matsuo and T Naoe for the Japan Adult Leukemia Study Group (JALSG)

Blood Cancer J 2014 4: e252; 10.1038/bcj.2014.72

Abstract | Full Text

Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma

F Liao, Y-C Hsu, S-H Kuo, Y-C Yang, J-P Chen, P-N Hsu, C-W Lin, L-T Chen, A-L Cheng, C S J Fann, J-T Lin and M-S Wu

Blood Cancer J 2014 4: eXX; 10.1038/bcj.2014.70

Abstract | Full Text

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma

R Silvennoinen, T Lundan, V Kairisto, T-T Pelliniemi, M Putkonen, P Anttila, V Huotari, P Mäntymaa, S Siitonen, L Uotila, T-L Penttilä, V Juvonen, T Selander and K Remes

Blood Cancer J 2014 4: e250; 10.1038/bcj.2014.69

Abstract | Full Text

Letters to the Editor

Top

Genetic diversity of newly diagnosed follicular lymphoma

Y W Asmann, M J Maurer, C Wang, V Sarangi, S M Ansell, A L Feldman, G S Nowakowski, M Manske, T Price-Troska, Z-Z Yang, S L Slager, T M Habermann, J R Cerhan and A J Novak

Blood Cancer J 2014 4: e256; 10.1038/bcj.2014.80

Full Text

Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course

R N Chavan, A G Bridges, R A Knudson, R P Ketterling, N Comfere, D A Wada, C Torres-Cabala, D J DiCaudo, G Vasmatzis, M R Pittelkow and A L Feldman

Blood Cancer J 2014 4: e253; 10.1038/bcj.2014.73

Full Text

Corrigendum

Top

The emerging role of Twist proteins in hematopoietic cells and hematological malignancies

N Merindol, A Riquet, V Szablewski, J-F Eliaou, A Puisieux and N Bonnefoy

Blood Cancer J 2014 4: e254; 10.1038/bcj.2014.81

Full Text

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: